Am. Paoletti et al., Short-term treatment with estradiol valerate (EV) plus cyproterone acetate(CPA) improves psychological status of postmenopausal women, 9TH INTERNATIONAL MENOPAUSE SOCIETY WORLD CONGRESS ON THE MENOPAUSE, 1999, pp. 227-231
The treatment with estradiol valerate (EV) plus cyproterone acetate (CPA) i
s capable of improving the majority of psychological symptoms, evaluated by
a validated psychometric scale (SCL-90), in postmenopausal women (PMW). Th
e treatment with estradiol (E2) shows to be less efficient than that with E
V+CPA. These results suggest that CPA enhances the neuronal activity of est
rogens.